The Key Role of IP<sub>6</sub>K: A Novel Target for Anticancer Treatments?
Inositol and its phosphate metabolites play a pivotal role in several biochemical pathways and gene expression regulation: inositol pyrophosphates (PP-IPs) have been increasingly appreciated as key signaling modulators. Fluctuations in their intracellular levels hugely impact the transfer of phospha...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-09-01
|
| Series: | Molecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1420-3049/25/19/4401 |
| _version_ | 1797552692558561280 |
|---|---|
| author | Mirko Minini Alice Senni Vittorio Unfer Mariano Bizzarri |
| author_facet | Mirko Minini Alice Senni Vittorio Unfer Mariano Bizzarri |
| author_sort | Mirko Minini |
| collection | DOAJ |
| description | Inositol and its phosphate metabolites play a pivotal role in several biochemical pathways and gene expression regulation: inositol pyrophosphates (PP-IPs) have been increasingly appreciated as key signaling modulators. Fluctuations in their intracellular levels hugely impact the transfer of phosphates and the phosphorylation status of several target proteins. Pharmacological modulation of the proteins associated with PP-IP activities has proved to be beneficial in various pathological settings. IP<sub>7</sub> has been extensively studied and found to play a key role in pathways associated with PP-IP activities. Three inositol hexakisphosphate kinase (IP<sub>6</sub>K) isoforms regulate IP<sub>7</sub> synthesis in mammals. Genomic deletion or enzymic inhibition of IP<sub>6</sub>K1 has been shown to reduce cell invasiveness and migration capacity, protecting against chemical-induced carcinogenesis. IP<sub>6</sub>K1 could therefore be a useful target in anticancer treatment. Here, we summarize the current understanding that established IP<sub>6</sub>K1 and the other IP<sub>6</sub>K isoforms as possible targets for cancer therapy. However, it will be necessary to determine whether pharmacological inhibition of IP<sub>6</sub>K is safe enough to begin clinical study. The development of safe and selective inhibitors of IP<sub>6</sub>K isoforms is required to minimize undesirable effects. |
| first_indexed | 2024-03-10T16:03:43Z |
| format | Article |
| id | doaj.art-774bc84ac19d4dad9d801b19a7be1504 |
| institution | Directory Open Access Journal |
| issn | 1420-3049 |
| language | English |
| last_indexed | 2024-03-10T16:03:43Z |
| publishDate | 2020-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Molecules |
| spelling | doaj.art-774bc84ac19d4dad9d801b19a7be15042023-11-20T15:02:31ZengMDPI AGMolecules1420-30492020-09-012519440110.3390/molecules25194401The Key Role of IP<sub>6</sub>K: A Novel Target for Anticancer Treatments?Mirko Minini0Alice Senni1Vittorio Unfer2Mariano Bizzarri3Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, ItalyDepartment of Experimental Medicine, Sapienza University of Rome, 00161 Rome, ItalySystems Biology Group Lab, Sapienza University of Rome, 00185 Rome, ItalyDepartment of Experimental Medicine, Sapienza University of Rome, 00161 Rome, ItalyInositol and its phosphate metabolites play a pivotal role in several biochemical pathways and gene expression regulation: inositol pyrophosphates (PP-IPs) have been increasingly appreciated as key signaling modulators. Fluctuations in their intracellular levels hugely impact the transfer of phosphates and the phosphorylation status of several target proteins. Pharmacological modulation of the proteins associated with PP-IP activities has proved to be beneficial in various pathological settings. IP<sub>7</sub> has been extensively studied and found to play a key role in pathways associated with PP-IP activities. Three inositol hexakisphosphate kinase (IP<sub>6</sub>K) isoforms regulate IP<sub>7</sub> synthesis in mammals. Genomic deletion or enzymic inhibition of IP<sub>6</sub>K1 has been shown to reduce cell invasiveness and migration capacity, protecting against chemical-induced carcinogenesis. IP<sub>6</sub>K1 could therefore be a useful target in anticancer treatment. Here, we summarize the current understanding that established IP<sub>6</sub>K1 and the other IP<sub>6</sub>K isoforms as possible targets for cancer therapy. However, it will be necessary to determine whether pharmacological inhibition of IP<sub>6</sub>K is safe enough to begin clinical study. The development of safe and selective inhibitors of IP<sub>6</sub>K isoforms is required to minimize undesirable effects.https://www.mdpi.com/1420-3049/25/19/4401inositol pyrophosphates (PP-IPs)diphosphoinositol pentakisphosphate (5-IP<sub>7</sub> or IP<sub>7</sub>)inositol hexakisphosphate kinase (IP<sub>6</sub>K)<i>myo</i>-inositolanticancer activity |
| spellingShingle | Mirko Minini Alice Senni Vittorio Unfer Mariano Bizzarri The Key Role of IP<sub>6</sub>K: A Novel Target for Anticancer Treatments? Molecules inositol pyrophosphates (PP-IPs) diphosphoinositol pentakisphosphate (5-IP<sub>7</sub> or IP<sub>7</sub>) inositol hexakisphosphate kinase (IP<sub>6</sub>K) <i>myo</i>-inositol anticancer activity |
| title | The Key Role of IP<sub>6</sub>K: A Novel Target for Anticancer Treatments? |
| title_full | The Key Role of IP<sub>6</sub>K: A Novel Target for Anticancer Treatments? |
| title_fullStr | The Key Role of IP<sub>6</sub>K: A Novel Target for Anticancer Treatments? |
| title_full_unstemmed | The Key Role of IP<sub>6</sub>K: A Novel Target for Anticancer Treatments? |
| title_short | The Key Role of IP<sub>6</sub>K: A Novel Target for Anticancer Treatments? |
| title_sort | key role of ip sub 6 sub k a novel target for anticancer treatments |
| topic | inositol pyrophosphates (PP-IPs) diphosphoinositol pentakisphosphate (5-IP<sub>7</sub> or IP<sub>7</sub>) inositol hexakisphosphate kinase (IP<sub>6</sub>K) <i>myo</i>-inositol anticancer activity |
| url | https://www.mdpi.com/1420-3049/25/19/4401 |
| work_keys_str_mv | AT mirkominini thekeyroleofipsub6subkanoveltargetforanticancertreatments AT alicesenni thekeyroleofipsub6subkanoveltargetforanticancertreatments AT vittoriounfer thekeyroleofipsub6subkanoveltargetforanticancertreatments AT marianobizzarri thekeyroleofipsub6subkanoveltargetforanticancertreatments AT mirkominini keyroleofipsub6subkanoveltargetforanticancertreatments AT alicesenni keyroleofipsub6subkanoveltargetforanticancertreatments AT vittoriounfer keyroleofipsub6subkanoveltargetforanticancertreatments AT marianobizzarri keyroleofipsub6subkanoveltargetforanticancertreatments |